*Based on published animal trial data in sheep and cattle
Our IP platform provides the opportunity to commercialise and develop unique, best-in-class products for a broad range of pain mitigation and wound care indications in livestock, companion animals and humans globally.
Partnering and business development is integral to our strategy of becoming a leader in woundcare pain mitigation. We have a number of strong and creative partnerships with innovative companies and research institutions that have advanced, and continue to advance, our business.
Medical Ethics has a proven platform technology and is focused on building a strong product portfolio within the field of woundcare pain mitigation.
Medical Ethics will consider out-licensing development and marketing rights to successful companies once key clinical milestones have been achieved.
To explore partnership opportunities, please contact our Business Development Team